Cat. No. 5806
Chemical Name: [3-[4-[2-[5-(Dimethyl-1,2-oxazol-4-
Biological ActivityDual CBP/p300 and BRD4 bromodomain inhibitor (IC50 values are 0.65 and 1.5 μM for CBP and BRD4 respectively). Downregulates IL-6, IL-1β and IFN-β in macrophages.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Chekler (2015) Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem.Biol. 22 1588. PMID: 26670081.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses ISOX DUAL from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: ISOX DUAL, supplier, Dual, CBP/p300, BRD4, bromodomains, inhibitors, inflammation, macrophages, inhibits, Tocris Bioscience, Bromodomain Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective inhibitor of cat eye syndrome chromosome region, candidate 2 (CECR2)NI 42
High affinity BRPF inhibitorBI 9564
Potent and selective BRD9 and BRD7 inhibitor; orally activeISOX INACT
Negative control for PF-CBP1 (Cat. No. 5801)
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.